APO Research
Talk to an analyst

APO RESEARCH · REPORT

Ophthalmic Drug Delivery System

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Ophthalmic Drug Delivery System Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

4 July 2026194 pages

Choose your research edition.

Industry ResearchOphthalmic Drug Delivery System Industry Research Report 2026149 pages · $2,950 USDIndustry Growth & TrendsGlobal Ophthalmic Drug Delivery System Industry Growth and Trends Forecast to 2032125 pages · $3,450 USDMarket StructureGlobal Ophthalmic Drug Delivery System Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Ophthalmic Drug Delivery System Market Outlook and Growth Opportunities 2026216 pages · $4,250 USDMarket Analysis & ForecastGlobal Ophthalmic Drug Delivery System Market Analysis and Forecast 2026-2032215 pages · $4,950 USD

Market perspective

The global Ophthalmic Drug Delivery System market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Ophthalmic Drug Delivery System is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Ophthalmic Drug Delivery System is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Ophthalmic Drug Delivery System is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Ophthalmic Drug Delivery System is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Ophthalmic Drug Delivery System include Aero Pump GmbH, AptarGroup, Bausch Health, Becton Dickinson & Company, Biocorp Production, Clearside Biomedical, Envisia Therapeutics, EyePoint Pharmaceuticals, Inc. and Gaplast GmbH, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Ophthalmic Drug Delivery System market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Ophthalmic Drug Delivery System and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Ophthalmic Drug Delivery System sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Ophthalmic Drug Delivery System market size, projected growth trends, production technologies, key applications, and end-use industries.

Ophthalmic Drug Delivery System Segment by Company

Aero Pump GmbH

AptarGroup

Bausch Health

Becton Dickinson & Company

Biocorp Production

Clearside Biomedical

Envisia Therapeutics

EyePoint Pharmaceuticals, Inc.

Gaplast GmbH

Gerresheimer

Graybug Vision

Kedalion Therapeutics

Mati Therapeutics, Inc.,

Nemera

Nipro Corporation

Ocular Therapeutix

Ocumedic, Inc.

Owen Mumford

Re-Vana Therapeutics

Santen Pharmaceutical

Silgan Holdings Inc.

Taiwan Liposome

Terumo Corporation

West Pharmaceutical Services, Inc.

Ophthalmic Drug Delivery System Segment by Type

Implantable Ophthalmic Drug Delivery Systems

Particulate Ophthalmic Drug Delivery Systems

Others

Ophthalmic Drug Delivery System Segment by Application

Clinics

Hospitals

Ambulatory Surgical Centers

Others

Ophthalmic Drug Delivery System Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Ophthalmic Drug Delivery System market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Ophthalmic Drug Delivery System and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Ophthalmic Drug Delivery System.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Ophthalmic Drug Delivery System market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Ophthalmic Drug Delivery System manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Ophthalmic Drug Delivery System in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Ophthalmic Drug Delivery System in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Ophthalmic Drug Delivery System Industry Trends Table 2. Ophthalmic Drug Delivery System Industry Drivers Table 3. Ophthalmic Drug Delivery System Industry Opportunities and Challenges Table 4. Ophthalmic Drug Delivery System Industry Restraints Table 5. Global Ophthalmic Drug Delivery System Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Ophthalmic Drug Delivery System Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Ophthalmic Drug Delivery System Sales by Manufacturers (k units) & (2021-2026) Table 8. Global Ophthalmic Drug Delivery System Sales Market Share by Manufacturers Table 9. Global Ophthalmic Drug Delivery System Average Sales Price (USD/unit) of Manufacturers (2021-2026) Table 10. Global Ophthalmic Drug Delivery System Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Ophthalmic Drug Delivery System Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Ophthalmic Drug Delivery System Manufacturers, Product Type & Application Table 13. Global Ophthalmic Drug Delivery System Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Ophthalmic Drug Delivery System by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Implantable Ophthalmic Drug Delivery Systems Table 17. Major Manufacturers of Particulate Ophthalmic Drug Delivery Systems Table 18. Major Manufacturers of Others Table 19. Global Ophthalmic Drug Delivery System Sales by Type 2021 VS 2025 VS 2032 (k units) Table 20. Global Ophthalmic Drug Delivery System Sales by Type (2021-2026) & (k units) Table 21. Global Ophthalmic Drug Delivery System Sales by Type (2027-2032) & (k units) Table 22. Global Ophthalmic Drug Delivery System Sales Market Share by Type (2021-2026) Table 23. Global Ophthalmic Drug Delivery System Sales Market Share by Type (2027-2032) Table 24. Global Ophthalmic Drug Delivery System Revenue by Type 2021 VS 2025 VS 2032 (k units) Table 25. Global Ophthalmic Drug Delivery System Revenue by Type (2021-2026) & (k units) Table 26. Global Ophthalmic Drug Delivery System Revenue by Type (2027-2032) & (k units) Table 27. Global Ophthalmic Drug Delivery System Revenue Market Share by Type (2021-2026) Table 28. Global Ophthalmic Drug Delivery System Revenue Market Share by Type (2027-2032) Table 29. Major Manufacturers of Clinics Table 30. Major Manufacturers of Hospitals Table 31. Major Manufacturers of Ambulatory Surgical Centers Table 32. Major Manufacturers of Others Table 33. Global Ophthalmic Drug Delivery System Sales by Application 2021 VS 2025 VS 2032 (k units) Table 34. Global Ophthalmic Drug Delivery System Sales by Application (2021-2026) & (k units) Table 35. Global Ophthalmic Drug Delivery System Sales by Application (2027-2032) & (k units) Table 36. Global Ophthalmic Drug Delivery System Sales Market Share by Application (2021-2026) Table 37. Global Ophthalmic Drug Delivery System Sales Market Share by Application (2027-2032) Table 38. Global Ophthalmic Drug Delivery System Revenue by Application 2021 VS 2025 VS 2032 (k units) Table 39. Global Ophthalmic Drug Delivery System Revenue by Application (2021-2026) & (k units) Table 40. Global Ophthalmic Drug Delivery System Revenue by Application (2027-2032) & (k units) Table 41. Global Ophthalmic Drug Delivery System Revenue Market Share by Application (2021-2026) Table 42. Global Ophthalmic Drug Delivery System Revenue Market Share by Application (2027-2032) Table 43. Global Ophthalmic Drug Delivery System Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 44. Global Ophthalmic Drug Delivery System Sales by Region (2021-2026) & (k units) Table 45. Global Ophthalmic Drug Delivery System Sales Market Share by Region (2021-2026) Table 46. Global Ophthalmic Drug Delivery System Sales Forecasted by Region (2027-2032) & (k units) Table 47. Global Ophthalmic Drug Delivery System Sales Forecasted Market Share by Region (2027-2032) Table 48. North America Ophthalmic Drug Delivery System Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 49. North America Ophthalmic Drug Delivery System Sales by Country (2021-2026) & (k units) Table 50. North America Ophthalmic Drug Delivery System Sales by Country (2027-2032) & (k units) Table 51. Europe Ophthalmic Drug Delivery System Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 52. Europe Ophthalmic Drug Delivery System Sales by Country (2021-2026) & (k units) Table 53. Europe Ophthalmic Drug Delivery System Sales by Country (2027-2032) & (k units) Table 54. Asia Pacific Ophthalmic Drug Delivery System Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 55. Asia Pacific Ophthalmic Drug Delivery System Sales by Country (2021-2026) & (k units) Table 56. Asia Pacific Ophthalmic Drug Delivery System Sales by Country (2027-2032) & (k units) Table 57. South America, Middle East and Africa Ophthalmic Drug Delivery System Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 58. South America, Middle East and Africa Ophthalmic Drug Delivery System Sales by Country (2021-2026) & (k units) Table 59. South America, Middle East and Africa Ophthalmic Drug Delivery System Sales by Country (2027-2032) & (k units) Table 60. Global Ophthalmic Drug Delivery System Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 61. Global Ophthalmic Drug Delivery System Revenue by Region (2021-2026) & (US$ Million) Table 62. Global Ophthalmic Drug Delivery System Revenue by Region (2027-2032) & (US$ Million) Table 63. Global Ophthalmic Drug Delivery System Revenue Market Share by Region (2021-2026) Table 64. Global Ophthalmic Drug Delivery System Revenue Market Share by Region (2027-2032) Table 65. Aero Pump GmbH Company Information Table 66. Aero Pump GmbH Business Overview Table 67. Aero Pump GmbH Ophthalmic Drug Delivery System Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. Aero Pump GmbH Ophthalmic Drug Delivery System Product Portfolio Table 69. Aero Pump GmbH Recent Development Table 70. AptarGroup Company Information Table 71. AptarGroup Business Overview Table 72. AptarGroup Ophthalmic Drug Delivery System Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. AptarGroup Ophthalmic Drug Delivery System Product Portfolio Table 74. AptarGroup Recent Development Table 75. Bausch Health Company Information Table 76. Bausch Health Business Overview Table 77. Bausch Health Ophthalmic Drug Delivery System Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. Bausch Health Ophthalmic Drug Delivery System Product Portfolio Table 79. Bausch Health Recent Development Table 80. Becton Dickinson & Company Company Information Table 81. Becton Dickinson & Company Business Overview Table 82. Becton Dickinson & Company Ophthalmic Drug Delivery System Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. Becton Dickinson & Company Ophthalmic Drug Delivery System Product Portfolio Table 84. Becton Dickinson & Company Recent Development Table 85. Biocorp Production Company Information Table 86. Biocorp Production Business Overview Table 87. Biocorp Production Ophthalmic Drug Delivery System Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 88. Biocorp Production Ophthalmic Drug Delivery System Product Portfolio Table 89. Biocorp Production Recent Development Table 90. Clearside Biomedical Company Information Table 91. Clearside Biomedical Business Overview Table 92. Clearside Biomedical Ophthalmic Drug Delivery System Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 93. Clearside Biomedical Ophthalmic Drug Delivery System Product Portfolio Table 94. Clearside Biomedical Recent Development Table 95. Envisia Therapeutics Company Information Table 96. Envisia Therapeutics Business Overview Table 97. Envisia Therapeutics Ophthalmic Drug Delivery System Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 98. Envisia Therapeutics Ophthalmic Drug Delivery System Product Portfolio Table 99. Envisia Therapeutics Recent Development Table 100. EyePoint Pharmaceuticals, Inc. Company Information Table 101. EyePoint Pharmaceuticals, Inc. Business Overview Table 102. EyePoint Pharmaceuticals, Inc. Ophthalmic Drug Delivery System Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 103. EyePoint Pharmaceuticals, Inc. Ophthalmic Drug Delivery System Product Portfolio Table 104. EyePoint Pharmaceuticals, Inc. Recent Development Table 105. Gaplast GmbH Company Information Table 106. Gaplast GmbH Business Overview Table 107. Gaplast GmbH Ophthalmic Drug Delivery System Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 108. Gaplast GmbH Ophthalmic Drug Delivery System Product Portfolio Table 109. Gaplast GmbH Recent Development Table 110. Gerresheimer Company Information Table 111. Gerresheimer Business Overview Table 112. Gerresheimer Ophthalmic Drug Delivery System Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 113. Gerresheimer Ophthalmic Drug Delivery System Product Portfolio Table 114. Gerresheimer Recent Development Table 115. Graybug Vision Company Information Table 116. Graybug Vision Business Overview Table 117. Graybug Vision Ophthalmic Drug Delivery System Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 118. Graybug Vision Ophthalmic Drug Delivery System Product Portfolio Table 119. Graybug Vision Recent Development Table 120. Kedalion Therapeutics Company Information Table 121. Kedalion Therapeutics Business Overview Table 122. Kedalion Therapeutics Ophthalmic Drug Delivery System Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 123. Kedalion Therapeutics Ophthalmic Drug Delivery System Product Portfolio Table 124. Kedalion Therapeutics Recent Development Table 125. Mati Therapeutics, Inc., Company Information Table 126. Mati Therapeutics, Inc., Business Overview Table 127. Mati Therapeutics, Inc., Ophthalmic Drug Delivery System Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 128. Mati Therapeutics, Inc., Ophthalmic Drug Delivery System Product Portfolio Table 129. Mati Therapeutics, Inc., Recent Development Table 130. Nemera Company Information Table 131. Nemera Business Overview Table 132. Nemera Ophthalmic Drug Delivery System Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 133. Nemera Ophthalmic Drug Delivery System Product Portfolio Table 134. Nemera Recent Development Table 135. Nipro Corporation Company Information Table 136. Nipro Corporation Business Overview Table 137. Nipro Corporation Ophthalmic Drug Delivery System Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 138. Nipro Corporation Ophthalmic Drug Delivery System Product Portfolio Table 139. Nipro Corporation Recent Development Table 140. Ocular Therapeutix Company Information Table 141. Ocular Therapeutix Business Overview Table 142. Ocular Therapeutix Ophthalmic Drug Delivery System Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 143. Ocular Therapeutix Ophthalmic Drug Delivery System Product Portfolio Table 144. Ocular Therapeutix Recent Development Table 145. Ocumedic, Inc. Company Information Table 146. Ocumedic, Inc. Business Overview Table 147. Ocumedic, Inc. Ophthalmic Drug Delivery System Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 148. Ocumedic, Inc. Ophthalmic Drug Delivery System Product Portfolio Table 149. Ocumedic, Inc. Recent Development Table 150. Owen Mumford Company Information Table 151. Owen Mumford Business Overview Table 152. Owen Mumford Ophthalmic Drug Delivery System Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 153. Owen Mumford Ophthalmic Drug Delivery System Product Portfolio Table 154. Owen Mumford Recent Development Table 155. Re-Vana Therapeutics Company Information Table 156. Re-Vana Therapeutics Business Overview Table 157. Re-Vana Therapeutics Ophthalmic Drug Delivery System Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 158. Re-Vana Therapeutics Ophthalmic Drug Delivery System Product Portfolio Table 159. Re-Vana Therapeutics Recent Development Table 160. Santen Pharmaceutical Company Information Table 161. Santen Pharmaceutical Business Overview Table 162. Santen Pharmaceutical Ophthalmic Drug Delivery System Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 163. Santen Pharmaceutical Ophthalmic Drug Delivery System Product Portfolio Table 164. Santen Pharmaceutical Recent Development Table 165. Silgan Holdings Inc. Company Information Table 166. Silgan Holdings Inc. Business Overview Table 167. Silgan Holdings Inc. Ophthalmic Drug Delivery System Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 168. Silgan Holdings Inc. Ophthalmic Drug Delivery System Product Portfolio Table 169. Silgan Holdings Inc. Recent Development Table 170. Taiwan Liposome Company Information Table 171. Taiwan Liposome Business Overview Table 172. Taiwan Liposome Ophthalmic Drug Delivery System Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 173. Taiwan Liposome Ophthalmic Drug Delivery System Product Portfolio Table 174. Taiwan Liposome Recent Development Table 175. Terumo Corporation Company Information Table 176. Terumo Corporation Business Overview Table 177. Terumo Corporation Ophthalmic Drug Delivery System Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 178. Terumo Corporation Ophthalmic Drug Delivery System Product Portfolio Table 179. Terumo Corporation Recent Development Table 180. West Pharmaceutical Services, Inc. Company Information Table 181. West Pharmaceutical Services, Inc. Business Overview Table 182. West Pharmaceutical Services, Inc. Ophthalmic Drug Delivery System Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 183. West Pharmaceutical Services, Inc. Ophthalmic Drug Delivery System Product Portfolio Table 184. West Pharmaceutical Services, Inc. Recent Development Table 185. Key Raw Materials Table 186. Raw Materials Key Suppliers Table 187. Ophthalmic Drug Delivery System Distributors List Table 188. Ophthalmic Drug Delivery System Customers List Table 189. Research Programs/Design for This Report Table 190. Authors List of This Report Table 191. Secondary Sources Table 192. Primary Sources List of Figures Figure 1. Ophthalmic Drug Delivery System Product Image Figure 2. Global Ophthalmic Drug Delivery System Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Ophthalmic Drug Delivery System Market Size (2021-2032) & (US$ Million) Figure 4. Global Ophthalmic Drug Delivery System Sales (2021-2032) & (k units) Figure 5. Global Ophthalmic Drug Delivery System Average Price (USD/unit) & (2021-2032) Figure 6. Global Top 5 and 10 Ophthalmic Drug Delivery System Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Implantable Ophthalmic Drug Delivery Systems Image Figure 9. Particulate Ophthalmic Drug Delivery Systems Image Figure 10. Others Image Figure 11. Global Ophthalmic Drug Delivery System Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 12. Global Ophthalmic Drug Delivery System Sales Market Share 2021 VS 2025 VS 2032 Figure 13. Global Ophthalmic Drug Delivery System Sales Market Share by Type (2021-2032) Figure 14. Global Ophthalmic Drug Delivery System Revenue by Type (2021 VS 2025 VS 2032) & (k units) Figure 15. Global Ophthalmic Drug Delivery System Revenue Market Share 2021 VS 2025 VS 2032 Figure 16. Global Ophthalmic Drug Delivery System Revenue Market Share by Type (2021-2032) Figure 17. Clinics Image Figure 18. Hospitals Image Figure 19. Ambulatory Surgical Centers Image Figure 20. Others Image Figure 21. Global Ophthalmic Drug Delivery System Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 22. Global Ophthalmic Drug Delivery System Sales Market Share 2021 VS 2025 VS 2032 Figure 23. Global Ophthalmic Drug Delivery System Sales Market Share by Application (2021-2032) Figure 24. Global Ophthalmic Drug Delivery System Revenue by Application (2021 VS 2025 VS 2032) & (k units) Figure 25. Global Ophthalmic Drug Delivery System Revenue Market Share 2021 VS 2025 VS 2032 Figure 26. Global Ophthalmic Drug Delivery System Revenue Market Share by Application (2021-2032) Figure 27. North America Ophthalmic Drug Delivery System Sales and Growth Rate (2021-2032) & (k units) Figure 28. North America Ophthalmic Drug Delivery System Sales Market Share by Country (2021-2032) Figure 29. U.S. Ophthalmic Drug Delivery System Sales and Growth Rate (2021-2032) & (k units) Figure 30. Canada Ophthalmic Drug Delivery System Sales and Growth Rate (2021-2032) & (k units) Figure 31. Mexico Ophthalmic Drug Delivery System Sales and Growth Rate (2021-2032) & (k units) Figure 32. Europe Ophthalmic Drug Delivery System Sales and Growth Rate (2021-2032) & (k units) Figure 33. Europe Ophthalmic Drug Delivery System Sales Market Share by Country (2021-2032) Figure 34. Germany Ophthalmic Drug Delivery System Sales and Growth Rate (2021-2032) & (k units) Figure 35. France Ophthalmic Drug Delivery System Sales and Growth Rate (2021-2032) & (k units) Figure 36. U.K. Ophthalmic Drug Delivery System Sales and Growth Rate (2021-2032) & (k units) Figure 37. Italy Ophthalmic Drug Delivery System Sales and Growth Rate (2021-2032) & (k units) Figure 38. Netherlands Ophthalmic Drug Delivery System Sales and Growth Rate (2021-2032) & (k units) Figure 39. Asia Pacific Ophthalmic Drug Delivery System Sales and Growth Rate (2021-2032) & (k units) Figure 40. Asia Pacific Ophthalmic Drug Delivery System Sales Market Share by Country (2021-2032) Figure 41. China Ophthalmic Drug Delivery System Sales and Growth Rate (2021-2032) & (k units) Figure 42. Japan Ophthalmic Drug Delivery System Sales and Growth Rate (2021-2032) & (k units) Figure 43. South Korea Ophthalmic Drug Delivery System Sales and Growth Rate (2021-2032) & (k units) Figure 44. Southeast Asia Ophthalmic Drug Delivery System Sales and Growth Rate (2021-2032) & (k units) Figure 45. India Ophthalmic Drug Delivery System Sales and Growth Rate (2021-2032) & (k units) Figure 46. Australia Ophthalmic Drug Delivery System Sales and Growth Rate (2021-2032) & (k units) Figure 47. South America, Middle East and Africa Ophthalmic Drug Delivery System Sales and Growth Rate (2021-2032) & (k units) Figure 48. South America, Middle East and Africa Ophthalmic Drug Delivery System Sales Market Share by Country (2021-2032) Figure 49. Brazil Ophthalmic Drug Delivery System Sales and Growth Rate (2021-2032) & (k units) Figure 50. South Africa Ophthalmic Drug Delivery System Sales and Growth Rate (2021-2032) & (k units) Figure 51. Saudi Arabia Ophthalmic Drug Delivery System Sales and Growth Rate (2021-2032) & (k units) Figure 52. Turkey Ophthalmic Drug Delivery System Sales and Growth Rate (2021-2032) & (k units) Figure 53. Argentina Ophthalmic Drug Delivery System Sales and Growth Rate (2021-2032) & (k units) Figure 54. UAE Ophthalmic Drug Delivery System Sales and Growth Rate (2021-2032) & (k units) Figure 55. Egypt Ophthalmic Drug Delivery System Sales and Growth Rate (2021-2032) & (k units) Figure 56. Chile Ophthalmic Drug Delivery System Sales and Growth Rate (2021-2032) & (k units) Figure 57. Global Ophthalmic Drug Delivery System Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Global Ophthalmic Drug Delivery System Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 59. North America Ophthalmic Drug Delivery System Revenue (2021-2032) & (US$ Million) Figure 60. North America Ophthalmic Drug Delivery System Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Europe Ophthalmic Drug Delivery System Revenue (2021-2032) & (US$ Million) Figure 62. Europe Ophthalmic Drug Delivery System Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. Asia-Pacific Ophthalmic Drug Delivery System Revenue (2021-2032) & (US$ Million) Figure 64. Asia-Pacific Ophthalmic Drug Delivery System Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. South America, Middle East and Africa Ophthalmic Drug Delivery System Revenue (2021-2032) & (US$ Million) Figure 66. South America, Middle East and Africa Ophthalmic Drug Delivery System Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 67. Ophthalmic Drug Delivery System Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Ophthalmic Drug Delivery System Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • Implantable Ophthalmic Drug Delivery Systems
  • Particulate Ophthalmic Drug Delivery Systems
  • Others
Applications
  • Clinics
  • Hospitals
  • Ambulatory Surgical Centers
  • Others
Companies covered
  • Aero Pump GmbH
  • AptarGroup
  • Bausch Health
  • Becton Dickinson & Company
  • Biocorp Production
  • Clearside Biomedical
  • Envisia Therapeutics
  • EyePoint Pharmaceuticals, Inc.
  • Gaplast GmbH
  • Gerresheimer
  • Graybug Vision
  • Kedalion Therapeutics
  • Mati Therapeutics, Inc.,
  • Nemera
  • Nipro Corporation
  • Ocular Therapeutix
  • Ocumedic, Inc.
  • Owen Mumford
  • Re-Vana Therapeutics
  • Santen Pharmaceutical
  • Silgan Holdings Inc.
  • Taiwan Liposome
  • Terumo Corporation
  • West Pharmaceutical Services, Inc.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Ophthalmic Drug Delivery System Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Ophthalmic Drug Delivery System Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Ophthalmic Drug Delivery System Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Ophthalmic Drug Delivery System Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Ophthalmic Drug Delivery System Market Dynamics
  1. 2.1 Ophthalmic Drug Delivery System Industry Trends
  2. 2.2 Ophthalmic Drug Delivery System Industry Drivers
  3. 2.3 Ophthalmic Drug Delivery System Industry Opportunities and Challenges
  4. 2.4 Ophthalmic Drug Delivery System Industry Restraints
3 Ophthalmic Drug Delivery System Market by Manufacturers
  1. 3.1 Global Ophthalmic Drug Delivery System Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Ophthalmic Drug Delivery System Sales by Manufacturers (2021-2026)
  3. 3.3 Global Ophthalmic Drug Delivery System Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Ophthalmic Drug Delivery System Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Ophthalmic Drug Delivery System Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Ophthalmic Drug Delivery System Manufacturers, Product Type & Application
  7. 3.7 Global Ophthalmic Drug Delivery System Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Ophthalmic Drug Delivery System Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Ophthalmic Drug Delivery System Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Ophthalmic Drug Delivery System Tier 1, Tier 2, and Tier 3
4 Ophthalmic Drug Delivery System Market by Type
  1. 4.1 Ophthalmic Drug Delivery System Type Introduction
  2. 4.1.1 Implantable Ophthalmic Drug Delivery Systems
  3. 4.1.2 Particulate Ophthalmic Drug Delivery Systems
  4. 4.1.3 Others
  5. 4.2 Global Ophthalmic Drug Delivery System Sales by Type
  6. 4.2.1 Global Ophthalmic Drug Delivery System Sales by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Ophthalmic Drug Delivery System Sales by Type (2021-2032)
  8. 4.2.3 Global Ophthalmic Drug Delivery System Sales Market Share by Type (2021-2032)
  9. 4.3 Global Ophthalmic Drug Delivery System Revenue by Type
  10. 4.3.1 Global Ophthalmic Drug Delivery System Revenue by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Ophthalmic Drug Delivery System Revenue by Type (2021-2032)
  12. 4.3.3 Global Ophthalmic Drug Delivery System Revenue Market Share by Type (2021-2032)
5 Ophthalmic Drug Delivery System Market by Application
  1. 5.1 Ophthalmic Drug Delivery System Application Introduction
  2. 5.1.1 Clinics
  3. 5.1.2 Hospitals
  4. 5.1.3 Ambulatory Surgical Centers
  5. 5.1.4 Others
  6. 5.2 Global Ophthalmic Drug Delivery System Sales by Application
  7. 5.2.1 Global Ophthalmic Drug Delivery System Sales by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Ophthalmic Drug Delivery System Sales by Application (2021-2032)
  9. 5.2.3 Global Ophthalmic Drug Delivery System Sales Market Share by Application (2021-2032)
  10. 5.3 Global Ophthalmic Drug Delivery System Revenue by Application
  11. 5.3.1 Global Ophthalmic Drug Delivery System Revenue by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Ophthalmic Drug Delivery System Revenue by Application (2021-2032)
  13. 5.3.3 Global Ophthalmic Drug Delivery System Revenue Market Share by Application (2021-2032)
6 Global Ophthalmic Drug Delivery System Sales by Region
  1. 6.1 Global Ophthalmic Drug Delivery System Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Ophthalmic Drug Delivery System Sales by Region (2021-2032)
  3. 6.2.1 Global Ophthalmic Drug Delivery System Sales by Region (2021-2026)
  4. 6.2.2 Global Ophthalmic Drug Delivery System Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Ophthalmic Drug Delivery System Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Ophthalmic Drug Delivery System Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Ophthalmic Drug Delivery System Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Ophthalmic Drug Delivery System Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Ophthalmic Drug Delivery System Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Ophthalmic Drug Delivery System Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Ophthalmic Drug Delivery System Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Ophthalmic Drug Delivery System Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Ophthalmic Drug Delivery System Revenue by Region
  1. 7.1 Global Ophthalmic Drug Delivery System Revenue by Region
  2. 7.1.1 Global Ophthalmic Drug Delivery System Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Ophthalmic Drug Delivery System Revenue by Region (2021-2026)
  4. 7.1.3 Global Ophthalmic Drug Delivery System Revenue by Region (2027-2032)
  5. 7.1.4 Global Ophthalmic Drug Delivery System Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Ophthalmic Drug Delivery System Revenue (2021-2032)
  8. 7.2.2 North America Ophthalmic Drug Delivery System Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Ophthalmic Drug Delivery System Revenue (2021-2032)
  11. 7.3.2 Europe Ophthalmic Drug Delivery System Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Ophthalmic Drug Delivery System Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Ophthalmic Drug Delivery System Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Ophthalmic Drug Delivery System Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Ophthalmic Drug Delivery System Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Aero Pump GmbH
  2. 8.1.1 Aero Pump GmbH Company Information
  3. 8.1.2 Aero Pump GmbH Business Overview
  4. 8.1.3 Aero Pump GmbH Ophthalmic Drug Delivery System Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Aero Pump GmbH Ophthalmic Drug Delivery System Product Portfolio
  6. 8.1.5 Aero Pump GmbH Recent Developments
  7. 8.2 AptarGroup
  8. 8.2.1 AptarGroup Company Information
  9. 8.2.2 AptarGroup Business Overview
  10. 8.2.3 AptarGroup Ophthalmic Drug Delivery System Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 AptarGroup Ophthalmic Drug Delivery System Product Portfolio
  12. 8.2.5 AptarGroup Recent Developments
  13. 8.3 Bausch Health
  14. 8.3.1 Bausch Health Company Information
  15. 8.3.2 Bausch Health Business Overview
  16. 8.3.3 Bausch Health Ophthalmic Drug Delivery System Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Bausch Health Ophthalmic Drug Delivery System Product Portfolio
  18. 8.3.5 Bausch Health Recent Developments
  19. 8.4 Becton Dickinson & Company
  20. 8.4.1 Becton Dickinson & Company Company Information
  21. 8.4.2 Becton Dickinson & Company Business Overview
  22. 8.4.3 Becton Dickinson & Company Ophthalmic Drug Delivery System Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Becton Dickinson & Company Ophthalmic Drug Delivery System Product Portfolio
  24. 8.4.5 Becton Dickinson & Company Recent Developments
  25. 8.5 Biocorp Production
  26. 8.5.1 Biocorp Production Company Information
  27. 8.5.2 Biocorp Production Business Overview
  28. 8.5.3 Biocorp Production Ophthalmic Drug Delivery System Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Biocorp Production Ophthalmic Drug Delivery System Product Portfolio
  30. 8.5.5 Biocorp Production Recent Developments
  31. 8.6 Clearside Biomedical
  32. 8.6.1 Clearside Biomedical Company Information
  33. 8.6.2 Clearside Biomedical Business Overview
  34. 8.6.3 Clearside Biomedical Ophthalmic Drug Delivery System Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Clearside Biomedical Ophthalmic Drug Delivery System Product Portfolio
  36. 8.6.5 Clearside Biomedical Recent Developments
  37. 8.7 Envisia Therapeutics
  38. 8.7.1 Envisia Therapeutics Company Information
  39. 8.7.2 Envisia Therapeutics Business Overview
  40. 8.7.3 Envisia Therapeutics Ophthalmic Drug Delivery System Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Envisia Therapeutics Ophthalmic Drug Delivery System Product Portfolio
  42. 8.7.5 Envisia Therapeutics Recent Developments
  43. 8.8 EyePoint Pharmaceuticals, Inc.
  44. 8.8.1 EyePoint Pharmaceuticals, Inc. Company Information
  45. 8.8.2 EyePoint Pharmaceuticals, Inc. Business Overview
  46. 8.8.3 EyePoint Pharmaceuticals, Inc. Ophthalmic Drug Delivery System Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 EyePoint Pharmaceuticals, Inc. Ophthalmic Drug Delivery System Product Portfolio
  48. 8.8.5 EyePoint Pharmaceuticals, Inc. Recent Developments
  49. 8.9 Gaplast GmbH
  50. 8.9.1 Gaplast GmbH Company Information
  51. 8.9.2 Gaplast GmbH Business Overview
  52. 8.9.3 Gaplast GmbH Ophthalmic Drug Delivery System Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Gaplast GmbH Ophthalmic Drug Delivery System Product Portfolio
  54. 8.9.5 Gaplast GmbH Recent Developments
  55. 8.10 Gerresheimer
  56. 8.10.1 Gerresheimer Company Information
  57. 8.10.2 Gerresheimer Business Overview
  58. 8.10.3 Gerresheimer Ophthalmic Drug Delivery System Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Gerresheimer Ophthalmic Drug Delivery System Product Portfolio
  60. 8.10.5 Gerresheimer Recent Developments
  61. 8.11 Graybug Vision
  62. 8.11.1 Graybug Vision Company Information
  63. 8.11.2 Graybug Vision Business Overview
  64. 8.11.3 Graybug Vision Ophthalmic Drug Delivery System Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Graybug Vision Ophthalmic Drug Delivery System Product Portfolio
  66. 8.11.5 Graybug Vision Recent Developments
  67. 8.12 Kedalion Therapeutics
  68. 8.12.1 Kedalion Therapeutics Company Information
  69. 8.12.2 Kedalion Therapeutics Business Overview
  70. 8.12.3 Kedalion Therapeutics Ophthalmic Drug Delivery System Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Kedalion Therapeutics Ophthalmic Drug Delivery System Product Portfolio
  72. 8.12.5 Kedalion Therapeutics Recent Developments
  73. 8.13 Mati Therapeutics, Inc.,
  74. 8.13.1 Mati Therapeutics, Inc., Company Information
  75. 8.13.2 Mati Therapeutics, Inc., Business Overview
  76. 8.13.3 Mati Therapeutics, Inc., Ophthalmic Drug Delivery System Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Mati Therapeutics, Inc., Ophthalmic Drug Delivery System Product Portfolio
  78. 8.13.5 Mati Therapeutics, Inc., Recent Developments
  79. 8.14 Nemera
  80. 8.14.1 Nemera Company Information
  81. 8.14.2 Nemera Business Overview
  82. 8.14.3 Nemera Ophthalmic Drug Delivery System Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Nemera Ophthalmic Drug Delivery System Product Portfolio
  84. 8.14.5 Nemera Recent Developments
  85. 8.15 Nipro Corporation
  86. 8.15.1 Nipro Corporation Company Information
  87. 8.15.2 Nipro Corporation Business Overview
  88. 8.15.3 Nipro Corporation Ophthalmic Drug Delivery System Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Nipro Corporation Ophthalmic Drug Delivery System Product Portfolio
  90. 8.15.5 Nipro Corporation Recent Developments
  91. 8.16 Ocular Therapeutix
  92. 8.16.1 Ocular Therapeutix Company Information
  93. 8.16.2 Ocular Therapeutix Business Overview
  94. 8.16.3 Ocular Therapeutix Ophthalmic Drug Delivery System Sales, Price, Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Ocular Therapeutix Ophthalmic Drug Delivery System Product Portfolio
  96. 8.16.5 Ocular Therapeutix Recent Developments
  97. 8.17 Ocumedic, Inc.
  98. 8.17.1 Ocumedic, Inc. Company Information
  99. 8.17.2 Ocumedic, Inc. Business Overview
  100. 8.17.3 Ocumedic, Inc. Ophthalmic Drug Delivery System Sales, Price, Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Ocumedic, Inc. Ophthalmic Drug Delivery System Product Portfolio
  102. 8.17.5 Ocumedic, Inc. Recent Developments
  103. 8.18 Owen Mumford
  104. 8.18.1 Owen Mumford Company Information
  105. 8.18.2 Owen Mumford Business Overview
  106. 8.18.3 Owen Mumford Ophthalmic Drug Delivery System Sales, Price, Revenue and Gross Margin (2021-2026)
  107. 8.18.4 Owen Mumford Ophthalmic Drug Delivery System Product Portfolio
  108. 8.18.5 Owen Mumford Recent Developments
  109. 8.19 Re-Vana Therapeutics
  110. 8.19.1 Re-Vana Therapeutics Company Information
  111. 8.19.2 Re-Vana Therapeutics Business Overview
  112. 8.19.3 Re-Vana Therapeutics Ophthalmic Drug Delivery System Sales, Price, Revenue and Gross Margin (2021-2026)
  113. 8.19.4 Re-Vana Therapeutics Ophthalmic Drug Delivery System Product Portfolio
  114. 8.19.5 Re-Vana Therapeutics Recent Developments
  115. 8.20 Santen Pharmaceutical
  116. 8.20.1 Santen Pharmaceutical Company Information
  117. 8.20.2 Santen Pharmaceutical Business Overview
  118. 8.20.3 Santen Pharmaceutical Ophthalmic Drug Delivery System Sales, Price, Revenue and Gross Margin (2021-2026)
  119. 8.20.4 Santen Pharmaceutical Ophthalmic Drug Delivery System Product Portfolio
  120. 8.20.5 Santen Pharmaceutical Recent Developments
  121. 8.21 Silgan Holdings Inc.
  122. 8.21.1 Silgan Holdings Inc. Company Information
  123. 8.21.2 Silgan Holdings Inc. Business Overview
  124. 8.21.3 Silgan Holdings Inc. Ophthalmic Drug Delivery System Sales, Price, Revenue and Gross Margin (2021-2026)
  125. 8.21.4 Silgan Holdings Inc. Ophthalmic Drug Delivery System Product Portfolio
  126. 8.21.5 Silgan Holdings Inc. Recent Developments
  127. 8.22 Taiwan Liposome
  128. 8.22.1 Taiwan Liposome Company Information
  129. 8.22.2 Taiwan Liposome Business Overview
  130. 8.22.3 Taiwan Liposome Ophthalmic Drug Delivery System Sales, Price, Revenue and Gross Margin (2021-2026)
  131. 8.22.4 Taiwan Liposome Ophthalmic Drug Delivery System Product Portfolio
  132. 8.22.5 Taiwan Liposome Recent Developments
  133. 8.23 Terumo Corporation
  134. 8.23.1 Terumo Corporation Company Information
  135. 8.23.2 Terumo Corporation Business Overview
  136. 8.23.3 Terumo Corporation Ophthalmic Drug Delivery System Sales, Price, Revenue and Gross Margin (2021-2026)
  137. 8.23.4 Terumo Corporation Ophthalmic Drug Delivery System Product Portfolio
  138. 8.23.5 Terumo Corporation Recent Developments
  139. 8.24 West Pharmaceutical Services, Inc.
  140. 8.24.1 West Pharmaceutical Services, Inc. Company Information
  141. 8.24.2 West Pharmaceutical Services, Inc. Business Overview
  142. 8.24.3 West Pharmaceutical Services, Inc. Ophthalmic Drug Delivery System Sales, Price, Revenue and Gross Margin (2021-2026)
  143. 8.24.4 West Pharmaceutical Services, Inc. Ophthalmic Drug Delivery System Product Portfolio
  144. 8.24.5 West Pharmaceutical Services, Inc. Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Ophthalmic Drug Delivery System Value Chain Analysis
  2. 9.1.1 Ophthalmic Drug Delivery System Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Ophthalmic Drug Delivery System Production Mode & Process
  6. 9.2 Ophthalmic Drug Delivery System Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Ophthalmic Drug Delivery System Distributors
  9. 9.2.3 Ophthalmic Drug Delivery System Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst